特赛纳公司(Techne Corporation)今日盘前大涨5.6%,引发市场广泛关注。公司今日公布的最新一季度财报显示,受益于旗下诊断和空间生物学部门的增长,公司净利润超出了分析师预期。
财报数据显示,特赛纳公司第一季度调整后每股盈利为0.42美元,高于分析师预期的0.38美元。公司当季总营收达到2.895亿美元,也超出了分析师的预期水平。其中,诊断和空间生物学部门营收同比增长14%至8320万美元,成为业绩增长的主要动力。
特赛纳公司CEO金-凯尔德曼表示,由于临床试验和细胞基因治疗领域的需求即将复苏,公司对生物技术终端市场的前景持乐观态度。该公司诊断设备和生物化合物产品在细胞疗法等新兴领域应用广泛,未来需求可期。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.